ResearchMoz

Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth

GBI Research
Published Date » 2013-05-14
No. Of Pages » N/A
   
 The leading business intelligence provider GBI Research has released its latest research report, entitled “Travel Vaccines Market to 2019 – Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth”. The report provides insights into the vaccines in the Travel Vaccines market including market forecasts up to 2019. It provides an in-depth analysis of the travel vaccines, as well as insights into the Travel Vaccines R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global Travel Vaccines market.  
   
 The report analyzes the market for Travel Vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. In addition, it...
Table of Contents  

1 Table of Contents  
1.1 List of Tables  
1.2 List of Figures  
 
2 Travel Vaccines Market to 2019: Introduction  
2.1 Overview  
 
3 Travel Vaccines Market to 2019: Overview  
3.1 Vaccine-Preventable Diseases  
3.1.1 Types of Vaccines  
3.2 Regulatory Framework  
3.2.1 US  
3.2.2 UK  
3.2.3 France  
3.2.4 Germany  
3.2.5 Italy  
3.2.6 Spain  
3.2.7 Japan  
3.3 Vaccine Manufacturing Process  
 
4 Travel Vaccines Market to 2019: Market Characterization and Forecast  
4.1 Revenue Forecast  
4.2 Market Share by Vaccine Type  
4.3 Market Share by Geography  
4.4 Traveling Population  
4.5 Drivers  
4.5.1 Aging Population and Increase in Global Tourist Traffic  
4.5.2 Novel Vaccine Technologies  
4.5.3 New and Novel Vaccines Launches Targeting High-Risk Populations  
4.6 Restraints  
4.6.1 Vaccine Supply Shortage Issues  
4.6.2 High Start-up Costs and Special Technical Expertise Requirements for Vaccine Production  
4.6.3 Public Acceptance  
4.6.4 Austerity Measures Leading to a Drop in Healthcare Funding  
 
5 Travel Vaccines Market to 2019: Hepatitis A Vaccines  
5.1 Disease Overview  
5.2 Market Forecasts  
5.2.1 US  
5.2.2 Top Five European Countries  
5.2.3 Japan  
5.3 Cost of Vaccination  
5.3.1 US  
5.3.2 Top Five European Countries  
5.3.3 Japan  
5.4 Pipeline Analysis  
5.4.1 Phase III (Inactive)  
5.4.2 Preclinical and Discovery (Inactive)  
 
6 Travel Vaccines Market to 2019: Hepatitis B Vaccines  
6.1 Disease Overview  
6.2 Market Forecasts  
6.2.1 US  
6.2.2 Top Five European Countries  
6.2.3 Japan  
6.3 Cost of Vaccination  
6.3.1 US  
6.3.2 Top Five European Countries  
6.3.3 Japan  
6.4 Pipeline Analysis  
6.4.1 Registration and Phase III  
6.4.2 Phase II  
6.4.3 Phase I  
6.4.4 Preclinical and Discovery  
 
7 Travel Vaccines Market to 2019: Japanese Encephalitis Vaccines  
7.1 Disease Overview  
7.2 Market Forecasts  
7.2.1 US  
7.2.2 Top Five European Countries  
7.2.3 Japan  
7.3 Cost of Vaccination  
7.3.1 US  
7.3.2 Top Five European Countries  
7.3.3 Japan  
7.4 Pipeline Analysis  
7.4.1 Registration  
7.4.2 Preclinical and Discovery  
 
8 Travel Vaccines Market to 2019: Meningococcal Vaccines  
8.1 Disease Overview  
8.2 Market Forecasts  
8.2.1 US  
8.2.2 Top Five European Countries  
8.3 Cost of Vaccination  
8.3.1 US  
8.3.2 Top Five European Countries  
8.4 Pipeline Analysis  
8.4.1 Registration and Phase III  
8.4.2 Phase II  
8.4.3 Preclinical and Discovery  
 
9 Travel Vaccines Market to 2019: Rabies Vaccines  
9.1 Disease Overview  
9.2 Market Forecasts  
9.2.1 US  
9.2.2 Top Five European Countries  
9.2.3 Japan  
9.3 Cost of Vaccination  
9.3.1 US  
9.3.2 Top Five European Countries  
9.3.3 Japan  
9.4 Pipeline Analysis  
9.4.1 Phase II  
9.4.2 Phase I  
9.4.3 Preclinical  
 
10 Travel Vaccines Market to 2019: Typhoid Vaccines  
10.1 Disease Overview  
10.2 Market Forecasts  
10.2.1 US  
10.2.2 Top Five European Countries  
10.3 Cost of Vaccination  
10.3.1 US  
10.3.2 Top Five European Countries  
10.4 Pipeline Analysis  
10.4.1 Phase II  
10.4.2 Preclinical  
 
11 Travel Vaccines Market to 2019: Yellow Fever Vaccines  
11.1 Disease Overview  
11.2 Market Forecasts  
11.2.1 US  
11.2.2 Top Five European Countries  
11.2.3 Japan  
11.3 Cost of Vaccination  
11.3.1 US  
11.3.2 Top Five European Countries  
11.3.3 Japan  
11.4 Pipeline Analysis  
11.4.1 Phase III  
11.4.2 Phase I  
11.4.3 Preclinical and Discovery  
 
12 Travel Vaccines Market to 2019: Competitive Landscape  
12.1 Introduction  
12.2 Major Company Profiles  
12.2.1 GlaxoSmithKline  
12.2.2 Sanofi  
12.2.3 Pfizer  
12.2.4 Merck  
12.2.5 Novartis  
 
13 Travel Vaccines Market to 2019: Strategic Consolidations  
13.1 Deals by Year  
13.2 Deals by Type  
13.3 Deals by Value  
13.4 Deals by Geography  
13.5 Summary of Major M&A Deals  
13.5.1 Gilead Sciences Completes Acquisition of Pharmasset for $11.2 Billion  
13.5.2 Johnson & Johnson Acquires Crucell  
13.6 Summary of Major Licensing Deals  
13.6.1 Intercell Enters into Licensing Agreement with Novartis for IC51  
13.6.2 Gilead Sciences Enters into Licensing Agreement with GlobeImmune  
 
14 Vaccines in Asia-Pacific – India, China and Australia: Overview  
14.1 India  
14.1.1 Regulatory Framework  
14.1.2 Major Company Profiles  
14.2 Recent Developments  
14.2.1 Biological E. Launches Japanese Encephalitis Vaccine Jeev in India – September 2012  
14.2.2 Approvals by Central Drugs Standard Control Organization  
14.3 China  
14.3.1 Regulatory Framework  
14.3.2 Expanded Programme on Immunization  
14.3.3 Major Company Profiles  
14.4 Australia  
14.4.1 Regulatory Framework  
14.4.2 Designated Vaccines and Circumstances in which Vaccines may be Provided  
14.4.3 Immunization Schedule  
14.4.4 Major Company Profiles  
14.4.5 Recent Developments  
14.5 Vaccines in Emerging Markets: Strategic Consolidations  
14.5.1 Deals by Year  
14.5.2 Deals by Type  
14.5.3 Deals by Value  
14.6 Vaccines in Emerging Markets: Pipeline by Phase  
 
15 Travel Vaccines Market to 2019: Appendix  
15.1 Market Definitions  
15.2 Abbreviations  
15.3 Bibliography  
15.4 Research Methodology  
15.4.1 Coverage  
15.4.2 Secondary Research  
15.4.3 Primary Research  
15.4.4 Model for Estimation of Vaccine Market  
15.5 Geographical Landscape  
15.6 Pipeline Analysis  
15.7 Competitive Landscape  
15.7.1 Expert Panel Validation  
15.8 Contact Us  
15.9 Disclaimer 

List of Tables


Table 1: Travel Vaccines Market, Top Seven Markets, Vaccine-Preventable Diseases, 2012 Table 2: Travel Vaccines Market, Top Seven Markets, Traveler Population (million), 2007–2012  
Table 3: Travel Vaccines Market, Top Seven Markets, Traveler Population Forecast (million), 2012–2019  
Table 4: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue ($m), 2007–2012  
Table 5: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019  
Table 6: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue ($m), 2007–2012  
Table 7: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019  
Table 8: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue ($m), 2007–2012  
Table 9: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019  
Table 10: Travel Vaccines Market, US, Hepatitis A Vaccines, Cost ($), 2007–2012  
Table 11: Travel Vaccines Market, US, Hepatitis A Vaccines, Cost ($), 2012–2019  
Table 12: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Cost ($), 2007–2012  
Table 13: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Cost Forecast ($), 2012–2019  
Table 14: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Cost ($), 2007–2012  
Table 15: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Cost Forecast ($), 2012–2019  
Table 16: Travel Vaccines Market, Global, Hepatitis A Vaccines, Phase III (Inactive) Pipeline, 2012  
Table 17: Travel Vaccines Market, Global, Hepatitis A Vaccines, Preclinical and Discovery (Inactive) Pipeline, 2012  
Table 18: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue ($m), 2007–2012  
Table 19: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019  
Table 20: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue ($m), 2007–2012  
Table 21: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019  
Table 22: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue ($m), 2007–2012  
Table 23: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019  
Table 24: Travel Vaccines Market, US, Hepatitis B Vaccines, Cost ($), 2007–2012  
Table 25: Travel Vaccines Market, US, Hepatitis B Vaccines, Cost Forecast ($), 2012–2019  
Table 26: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Cost ($), 2007–2012  
Table 27: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Cost ($), 2012–2019  
Table 28: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Cost ($), 2007–2012  
Table 29: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Cost Forecast ($), 2012–2019  
Table 30: Travel Vaccines Market, Global, Hepatitis B Vaccines, Registration and Phase III Pipeline, 2012  
Table 31: Travel Vaccines Market, Global, Hepatitis B Vaccines, Phase II Pipeline, 2012  
Table 32: Travel Vaccines Market, Global, Hepatitis B Vaccines, Phase I Pipeline, 2012  
Table 33: Travel Vaccines Market, Global, Hepatitis B Vaccines, Preclinical and Discovery Pipeline, 2012  
Table 34: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012  
Table 35: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2012–2019  
Table 36: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012  
Table 37: Travel Vaccines Market to 2019, Japanese Encephalitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2012–2019  
Table 38: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012  
Table 39: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2012–2019  
Table 40: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Cost ($), 2007–2012  
Table 41: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019  
Table 42: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Cost ($), 2007–2012  
Table 43: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019  
Table 44: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Cost ($), 2007–2012  
Table 45: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019  
Table 46: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Registration, 2012  
Table 47: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Preclinical and Discovery, 2012  
Table 48: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue ($m), 2007–2012  
Table 49: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue Forecast ($m), 2012–2019  
Table 50: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue ($m), 2007–2012  
Table 51: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue Forecast ($m), 2012–2019  
Table 52: Travel Vaccines Market, US, Meningococcal Vaccines, Cost ($), 2007–2012  
Table 53: Travel Vaccines Market, US, Meningococcal Vaccines, Cost Forecast ($), 2012–2019  
Table 54: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Cost ($), 2007–2012  
Table 55: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Cost Forecast ($), 2012–2019  
Table 56: Travel Vaccines Market, Global, Meningococcal Vaccines, Registration and Phase III Pipeline, 2012  
Table 57: Travel Vaccines Market, Global, Meningococcal Vaccines, Phase II Pipeline, 2012  
Table 58: Travel Vaccines Market, Global, Meningococcal Vaccines, Preclinical Pipeline, 2012  
Table 59: Travel Vaccines Market, US, Rabies Vaccines, Revenue ($m), 2007–2012  
Table 60: Travel Vaccines Market, US, Rabies Vaccines, Revenue Forecast ($m), 2012–2019  
Table 61: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue ($m), 2007–2012  
Table 62: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue Forecast ($m), 2012–2019  
Table 63: Travel Vaccines Market, Japan, Rabies Vaccines, Revenue ($m), 2007–2012  
Table 64: Travel Vaccines Market, Japan, Rabies Vaccines, Revenue Forecast ($m), 2012–2019  
Table 65: Travel Vaccines Market, US, Rabies Vaccines, Cost ($), 2007–2012  
Table 66: Travel Vaccines Market, US, Rabies Vaccines, Cost Forecast ($), 2012–2019  
Table 67: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Cost ($), 2007–2012  
Table 68: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Cost Forecast ($), 2012–2019  
Table 69: Travel Vaccines Market, Japan, Rabies Vaccines, Cost ($), 2007–2012  
Table 70: Travel Vaccines Market, Japan. Rabies Vaccines, Cost Forecast ($), 2012–2019  
Table 71: Travel Vaccines Market, Global, Rabies Vaccines, Phase II Pipeline, 2012  
Table 72: Travel Vaccines Market, Global, Rabies Vaccines, Phase I Pipeline, 2012  
Table 73: Travel Vaccines Market, Global, Rabies Vaccines, Preclinical Pipeline, 2012  
Table 74: Travel Vaccines Market, US, Typhoid Vaccines, Revenue ($m), 2007–2012  
Table 75: Travel Vaccines Market, US, Typhoid Vaccines, Revenue Forecast ($m), 2012–2019  
Table 76: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue ($m), 2007–2012  
Table 77: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue Forecast ($m), 2012–2019  
Table 78: Travel Vaccines Market, US, Typhoid Vaccines, Cost ($), 2007–2012  
Table 79: Travel Vaccines Market, US, Typhoid Vaccines, Cost Forecast ($), 2012–2019  
Table 80: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Cost ($), 2007–2012  
Table 81: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Cost Forecast ($), 2012–2019  
Table 82: Travel Vaccines Market, Global, Typhoid Vaccines, Phase II Pipeline, 2012  
Table 83: Travel Vaccines Market, Global, Typhoid Vaccines, Preclinical Pipeline, 2012  
Table 84: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue ($m), 2007–2012  
Table 85: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019  
Table 86: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue ($m), 2007–2012  
Table 87: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019  
Table 88: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue ($m), 2007–2012  
Table 89: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019  
Table 90: Travel Vaccines Market, US, Yellow Fever Vaccines, Cost ($), 2007–2012  
Table 91: Travel Vaccines Market, US, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019  
Table 92: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Cost ($), 2007–2012  
Table 93: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019  
Table 94: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Cost ($), 2007–2012  
Table 95: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019  
Table 96: Travel Vaccines Market, Global, Yellow Fever Vaccines, Phase III, 2012  
Table 97: Travel Vaccines Market, Global, Yellow Fever Vaccines, Phase I, 2012  
Table 98: Travel Vaccines Market, Global, Yellow Fever Vaccines, Preclinical and Discovery, 2012  
Table 99: Travel Vaccines Market, India, Immunization Schedule, 2012  
Table 100: Travel Vaccines Market, India, Major Vaccine Brands by Indication, 2012  
Table 101: Travel Vaccines Market, China, Policies, 2012  
Table 102: Travel Vaccines Market, Australia, Designated Bacterial Vaccines and Circumstances in which Vaccines may be Provided, 2011  
Table 103: Travel Vaccines Market, Australia, Designated Viral Vaccines and Circumstances in which Vaccines may be Provided, 2011  
Table 104: Travel Vaccines Market, Australia, Designated Combined Bacterial and Viral Vaccines and Circumstances in which Vaccines may be Provided, 2011  
Table 105: Travel Vaccines Market, Australia, Immunization Schedule, 2012  
Table 106: Travel Vaccines Market, Emerging Markets, Pipeline by Phase, 2012 

List of Figures


Figure 1: Travel Vaccines Market, Global, Vaccine Types, 2012  
Figure 2: Travel Vaccines Market, Global, Vaccine Manufacturing Process, 2012  
Figure 3: Travel Vaccines Market, Top Seven Markets, Revenue Forecast ($m), 2007–2019 
Figure 4: Travel Vaccines Market, Top Seven Markets, Market Share by Vaccine Type (%), 2012  
Figure 5: Travel Vaccines Market, Top Seven Markets, Market Share by Geography (%), 2012  
Figure 6: Travel Vaccines Market, Top Seven Markets, Traveling Population (million), 2007–2019  
Figure 7: Travel Vaccines Market, Global, Geographical Distribution of Hepatitis A, 2012  
Figure 8: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 9: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 10: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 11: Travel Vaccines Market, Global, Hepatitis A Vaccines, Pipeline by Phase (%), 2012  
Figure 12: Travel Vaccines Market, Global, Geographical Distribution of Hepatitis B, 2012  
Figure 13: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 14: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 15: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 16: Travel Vaccines Market, Global, Hepatitis B Vaccines, Pipeline by Phase (%), 2012  
Figure 17: Travel Vaccines Market, Global, Geographical Distribution of Japanese Encephalitis, 2012  
Figure 18: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 19: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 20: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 21: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Pipeline by Phase (%), 2012  
Figure 22: Travel Vaccines Market, Global, Geographical Distribution of Meningococcal Meningitis, 2012  
Figure 23: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 24: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 25: Travel Vaccines Market, Global, Meningococcal Vaccines, Pipeline by Phase (%), 2012  
Figure 26: Travel Vaccines Market, Global, Geographical Distribution of Rabies, 2012  
Figure 27: Travel Vaccines Market, US, Rabies Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 28: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 29: Travel Vaccines Market, Japan. Rabies Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 30: Travel Vaccines Market, Global, Rabies Vaccines, Pipeline by Phase (%), 2012  
Figure 31: Travel Vaccines Market, Global, Geographical Distribution of Typhoid, 2012  
Figure 32: Travel Vaccines Market, US, Typhoid Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 33: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 34: Travel Vaccines Market, Global, Typhoid Vaccines, Pipeline by Phase (%), 2012  
Figure 35: Travel Vaccines Market, Global, Geographical Distribution of Yellow Fever, 2012  
Figure 36: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 37: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 38: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue Forecast ($m), 2007–2019  
Figure 39: Travel Vaccines Market, Global, Yellow Fever Vaccines, Pipeline by Phase (%), 2012  
Figure 40: GlaxoSmithKline, Travel Vaccines Market, SWOT Analysis, 2012  
Figure 41: Sanofi, Travel Vaccines Market, SWOT Analysis, 2012  
Figure 42: Pfizer, Travel Vaccines Market, SWOT Analysis, 2012  
Figure 43: Merck, Travel Vaccines Market, SWOT Analysis, 2012  
Figure 44: Novartis, Travel Vaccines Market, SWOT Analysis, 2012  
Figure 45: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Year, 2009–2013  
Figure 46: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Type, 2008–2013  
Figure 47: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Value, 2008–2013  
Figure 48: Travel Vaccines Market, Global, Strategic Consolidations, Deals by Geography, 2008–2013  
Figure 49: Vaccines in Emerging Markets, India, National Rural Health Mission, 2011  
Figure 50: Vaccines in Emerging Markets, Deals by Year, 2009–2013  
Figure 51: Travel Vaccines Market, Emerging Markets, Deals by Type (%), 2009–2013  
Figure 52: Travel Vaccines Market, Emerging Markets, Deals by Value ($m), 2009–2013  
Figure 53: Travel Vaccines Market, Emerging Markets, Pipeline by Phase (%), 2012  
Figure 54: GBI Research Market Forecasting Model 

Upcoming Reports:

Multi-Factor Authentication Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The global multi-factor authentication (MFA) market has shown remarkable progress in the recent years and is also showing attractive market potential for the future. North America and Europe hold the largest market share of the global MFA market and Asia-Pacific is expected to be the fastest growing region in the coming years. The market is segmented into three major categories on the basis of model types into: two factor authentication, three factor authentication, and four factor authentication. It is divided into five major categories on the basis of applications into government,...
Gravure Printing Ink Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Gravure or rotogravure is a printing process which involves engraving of an image over the carrier. Similar to off-set printing and flexography, the image is engraved on a cylinder in gravure printing, and it uses a rotary printing press. Earlier gravure printing was used to print newspapers. It is still used in the commercial production of magazines, product packaging and postcards. Gravure inks are of two types, viz., water based and solvent based. Solvent based inks are preferred as it requires less time to dry, and the printing process is swifter. Water based inks typically take longer...
Multi-Infarct Dementia (MID) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Multi-infarct dementia (MID) is one of the common causes of memory loss among elderly people as a result of reduced blood flow to parts of the brain. The primary reason for multi-infarct dementia is a series of minor strokes resulting in disruption of blood flow leading towards the brain. Since this medical condition arises due to problematic vessels, it is also known as vascular dementia (VaD). Multi-infarct dementia commonly affects people of age group 55 to 75 years. According to the National Institutes of Health, multi-infarct dementia is the second leading form of dementia,...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

SESI Project Kick Starts with a Grand Opening
Apr 20, 2015  
On Thursday, the Stanford Energy Systems Innovations (SESI) project succeeded with the grand opening of their Central Energy Facility which is located close to the golf course. The facility has provided with a private tour and reception, and introduced John Hennessy as the President of University, Tom Werner as the President and CEO of SunPower, and other executives and officials of...
China Is Planning to Shut Down Most of its Coal Plants
Apr 20, 2015  
China has been taking some efforts to scrap some of its small-sized coal plants which will avoid releasing about 11.4 million metric tons every year of carbon dioxide which was warming the climate and helping the whole nation with reduced emissions. This reduction will be for the first time in almost a decade. This impact is a hint of what is going to happen in China which will push...
CPEC to be on the High-Agenda in the Two Day Pakistan Visit of Chinese President
Apr 20, 2015  
According to Xinhua, a lot of deals varying from infrastructure to energy to culture and education will be signed and agreed during the two-day visit of China President Xi Jinping in Pakistan visit which will begin from Monday.This will be Xi Jinping’s first visit among all the South Asian countries from 2013, from when he holds the position of the presidentship. During the...
China Reduces Bank Reserve Requirement to Overcome Slowdown
Apr 20, 2015  
The central bank of China on Sunday reduced the amount of capital, which banks must maintain as reserves. This reduction is the second cut in 2 months that will affect the entire industry, by adding additional liquidity to the second-largest economy of the world in supporting to promote bank lending and fight declining growth rate. The PBOC (People's Bank of China) has decreased the...
ICICI Bank Partners with Tech Mahindra, Rolled out Tap-n-Pay Service
Apr 20, 2015  
One of the leading private sector banks in India, ICICI Bank, has entered into a partnership with Tech Mahindra to roll out the contactless payment service, named 'Tap-n-Pay'. ICICI Bank stated in an announcement that based on the NFC (Near Field Communications) technology, this payment method enables anyone, irrespective of having an account with ICICI, to make over-the-counter...